We are live on
!
Find out more
SVA
Sinovac Biotech, Ltd
SVA
SVA
Delisted
SVA was delisted on the 22nd of February, 2019.
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
O
1
OrbiMed
New York
| $340M | – | – | – |
|
|
VC
2
Vivo Capital
Palo Alto,
California
| $76.3M | – | – | – |
|
|
NAH
3
Neumann Advisory (HK)
Central,
Hong Kong
| $2.04M | – | – | – |
|
4
Renaissance Technologies
New York
| $849K | – | – | – |
|
5
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| $106K | – | – | – |
|
6
Geode Capital Management
Boston,
Massachusetts
| $89.7K | – | – | – |
|
7
Wells Fargo
San Francisco,
California
| $80.6K | -$1.94K | -300 | -2% |
|
8
Morgan Stanley
New York
| $50.6K | +$5.82K | +900 | +13% |
|
9
UBS Group
Zurich,
Switzerland
| $10.1K | -$3.48K | -538 | -26% |
|
10
Group One Trading
Chicago,
Illinois
| $2.67K | – | – | – |
|
|
TFA
11
Transamerica Financial Advisors
St. Petersburg,
Florida
| $1K | – | – | – |
|
|
HI
12
Horizon Investments
Charlotte,
North Carolina
| $336 | – | – | – |
|
13
State Street
Boston,
Massachusetts
| – | -$1.04M | -160,875 | Closed |
|
14
JP Morgan Chase
New York
| – | -$19.4K | -3,000 | Closed |
|